Status:

COMPLETED

Hypoxic Exercise and Glucose Metabolism

Lead Sponsor:

Maastricht University Medical Center

Conditions:

Obesity

Insulin Resistance

Eligibility:

MALE

30-70 years

Phase:

NA

Brief Summary

The obesity epidemic calls for new therapeutic opportunities to prevent and treat obesity and its comorbidities amongst which are insulin resistance and cardiovascular diseases. Recent evidence sugges...

Detailed Description

In the present randomized, single-blind, placebo-controlled cross-over study, subjects will be exposed to normobaric 1) mild hypoxia (oxygen level: 15%) and 2) normoxia (oxygen level: 21%) during exer...

Eligibility Criteria

Inclusion

  • overweight or obese (BMI \>28 kg/m2)
  • impaired glucose tolerance (2h glucose: \>7.8 - 11.1 mmol/L)
  • subjects have to be weight-stable for at least 3 months prior to participation (no change in bodyweight: \<3kg change)

Exclusion

  • cardiovascular disease (determined by questionnaire, blood pressure (Subjects with moderate to severe hypertension (grade 2 or 3 based on WHO criteria)
  • type 2 diabetes mellitus
  • cancer
  • asthma
  • bronchitis
  • chronic obstructive pulmonary disease
  • lung fibrosis
  • obstructive sleep apnea
  • use of oxygen at home situation
  • resting SpO2 ≤93%
  • abnormal pre-bronchodilator forced expiratory volume (FEV1) and forced vital capacity (FVC)
  • liver or kidney malfunction (determined based on ALAT and creatinine levels, respectively)
  • disease with a life expectancy shorter then 5 years
  • lactose intolerance
  • abuse of products (alcohol consumption \> 15 units/week)
  • smoking
  • plans to lose weight (subjects will be asked if they have weight loss plans (e.g. to increase their physical activity level or change diet)
  • use of high doses of anti-oxidant vitamins
  • use of any medication that influences glucose metabolism and inflammation
  • shift working

Key Trial Info

Start Date :

July 22 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 18 2020

Estimated Enrollment :

11 Patients enrolled

Trial Details

Trial ID

NCT04280991

Start Date

July 22 2019

End Date

December 18 2020

Last Update

November 1 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Human Biology, Maastricht University Medical Centre

Maastricht, Netherlands, 6200MD